1094 / 1851
Rationale for Prophylactic Cranial Irradiation in SCLC
Brain metastases are very common (50-75% at 2 years)
Insufficient drugs supply in brain (BBB)
Relative increase of brain relapse in long-term survivors
Response rate in brain disease < 50%